The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

Shares of WW International Inc., known as WeightWatchers, soared 18% Tuesday, after the weight-management company announced the addition of compounded GLP-1 obesity treatments to its offering.

This expanded the Company’s offerings to include high-touch clinical weight management solutions alongside its science-backed behavioral programs,” WeightWatchers said in a press release.

Lower Manhattan-based Metsera is one of the latest drug startups to throw its hat into the ring with the pharma giants ...

Weight loss is not a one-size-fits-all solution. What works for one person may not work for another, and even the most effective treatments may need adjustments over time. That’s why ScriptsMD’s ...

NYC Health + Hospitals/Queens held a ribbon-cutting ceremony last month to celebrate the launch of its new Weight Management ...

NEW YORK - WeightWatchers (NASDAQ: WW) introduced compounded semaglutide to its weight management program, aiming to provide members with a clinically supported treatment option in the face of ...